Search Results - "Maisonneuve, I M"

Refine Results
  1. 1

    18-MC reduces methamphetamine and nicotine self-administration in rats by Glick, S D, Maisonneuve, I M, Dickinson, H A

    Published in Neuroreport (26-06-2000)
    “…In previous studies, 18-methoxycoronaridine (18-MC), a novel iboga alkaloid congener, has been found to decrease the intravenous self-administration of…”
    Get full text
    Journal Article
  2. 2

    U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats by Maisonneuve, I M, Archer, S, Glick, S D

    Published in Neuroscience letters (07-11-1994)
    “…Because an increase in extracellular levels of dopamine in the nucleus accumbens has been associated with the reinforcing effects of addictive drugs, we…”
    Get more information
    Journal Article
  3. 3

    Synthesis and Biological Evaluation of 18-Methoxycoronaridine Congeners. Potential Antiaddiction Agents by Kuehne, Martin E, He, Liwen, Jokiel, Patrick A, Pace, C. J, Fleck, M. W, Maisonneuve, I. M, Glick, Stanley D, Bidlack, Jean M

    Published in Journal of medicinal chemistry (19-06-2003)
    “…Variation of the methoxycarbonyl and C-18 substituents of the antiaddictive compound 18-methoxycoronaridine, and contraction of its isoquinuclidine ring…”
    Get full text
    Journal Article
  4. 4

    Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment by Maisonneuve, Isabelle M., Glick, Stanley D.

    Published in Pharmacology, biochemistry and behavior (01-06-2003)
    “…18-Methoxycoronaridine (18-MC), a novel iboga alkaloid congener that decreases drug self-administration in several animal models, may be a potential treatment…”
    Get full text
    Journal Article
  5. 5

    Kappa opioid inhibition of morphine and cocaine self-administration in rats by Glick, Stanley D., Maisonneuve, Isabelle M., Raucci, John, Sydney, Archer

    Published in Brain research (29-05-1995)
    “…Two kappa agonists, U50,488 and spiradoline, produced dose-related acute decreases in both morphine and cocaine self-administration in rats; higher doses of…”
    Get full text
    Journal Article
  6. 6

    Chronic administration of a cocaine "binge" alters basal extracellular levels in male rats: an in vivo microdialysis study by Maisonneuve, I M, Ho, A, Kreek, M J

    “…The purpose of this study was to determine the effects of chronic "binge" administration of cocaine (hourly x 3 i.p.). Male Fisher rats were treated for 13…”
    Get more information
    Journal Article
  7. 7

    Acute tolerance to the dopamine response induced by a binge pattern of cocaine administration in male rats: an in vivo microdialysis study by Maisonneuve, I M, Kreek, M J

    “…To address a growing concern about the relevance of the pattern of cocaine administration used in animal studies, the aim of the present work was to establish…”
    Get more information
    Journal Article
  8. 8

    18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats by Glick, S.D., Kuehne, M.E., Maisonneuve, I.M., Bandarage, U.K., Molinari, H.H.

    Published in Brain research (06-05-1996)
    “…Ibogaine, a naturally occurring iboga alkaloid, has been claimed to be effective in treating addiction to opioids and stimulants, and has been reported to…”
    Get full text
    Journal Article
  9. 9

    18-Methoxycoronaridine (18-MC) and Ibogaine: Comparison of Antiaddictive Efficacy, Toxicity, and Mechanisms of Action by GLICK, STANLEY D., MAISONNEUVE, ISABELLE M., SZUMLINSKI, KAREN K.

    Published in Annals of the New York Academy of Sciences (01-09-2000)
    “…18‐MC, a novel iboga alkaloid congener, is being developed as a potential treatment for multiple forms of drug abuse. Like ibogaine (40 mg/kg), 18‐MC (40…”
    Get full text
    Journal Article
  10. 10

    Effects and aftereffects of ibogaine on morphine self-administration in rats by Glick, S D, Rossman, K, Steindorf, S, Maisonneuve, I M, Carlson, J N

    Published in European journal of pharmacology (03-04-1991)
    “…Ibogaine, a naturally occurring alkaloid, has been claimed to be effective in treating addition to opiate and stimulant drugs. As a preclinical test of this…”
    Get more information
    Journal Article
  11. 11

    An oral self-administration model of nicotine preference in rats : effects of mecamylamine by GLICK, S. D, VISKER, K. E, MAISONNEUVE, I. M

    Published in Psychopharmacologia (01-12-1996)
    “…A new oral model of nicotine self-administration in rats has been described. The model utilizes a two-lever operant procedure with rats having a choice between…”
    Get full text
    Journal Article
  12. 12

    Acute iboga alkaloid effects on extracellular serotonin (5-HT) levels in nucleus accumbens and striatum in rats by Wei, D., Maisonneuve, I.M., Kuehne, M.E., Glick, S.D.

    Published in Brain research (03-08-1998)
    “…The iboga alkaloid, ibogaine, its metabolite, noribogaine, and the congener, 18-methoxycoronaridine (18-MC) have all been claimed to have anti-addictive…”
    Get full text
    Journal Article
  13. 13

    Interactions between iboga agents and methamphetamine sensitization: studies of locomotion and stereotypy in rats by Szumlinski, K K, Balogun, M Y, Maisonneuve, I M, Glick, S D

    Published in Psychopharmacology (01-08-2000)
    “…The phenomenon of sensitization has been theoretically implicated in mediating various aspects of drug addiction. Recent dose-response studies demonstrated…”
    Get full text
    Journal Article
  14. 14

    (±)Cyclazocine blocks the dopamine response to nicotine by Maisonneuve, I M, Glick, S D

    Published in Neuroreport (17-03-1999)
    “…(±)CYCLAZOCINE, synthesized by Archer in 1962, was originally tested as a treatment for heroin addiction. (±)Cyclazocine is a mu opioid antagonist and kappa…”
    Get full text
    Journal Article
  15. 15

    18-Methoxycoronardine attenuates nicotine-induced dopamine release and nicotine preferences in rats by GLICK, S. D, MAISONNEUVE, I. M, VISKER, K. E, FRITZ, K. A, BANDARAGE, U. K, KUEHNE, M. E

    Published in Psychopharmacologia (01-10-1998)
    “…Two studies were conducted to assess, in vivo, potential anti-nicotinic effects of the iboga alkaloid ibogaine and its synthetic congener…”
    Get full text
    Journal Article
  16. 16

    Enantioselective behavioral effects of sibutramine metabolites by Glick, Stanley D., Haskew, Renee E., Maisonneuve, Isabelle M., Carlson, Jeffrey N., Jerussi, Thomas P.

    Published in European journal of pharmacology (26-05-2000)
    “…The anti-obesity agent, racemic ( RS)-sibutramine, has two active metabolites, desmethylsibutramine and didesmethylsibutramine. To the extent that sibutramine…”
    Get full text
    Journal Article
  17. 17

    Ibogaine-like effects of noribogaine in rats by Glick, S.D., Pearl, S.M., Cai, J., Maisonneuve, I.M.

    Published in Brain research (25-03-1996)
    “…Ibogaine is a naturally occurring alkaloid that has been claimed to be effective in treating addiction to opioids and stimulants; a single dose is claimed to…”
    Get full text
    Journal Article
  18. 18

    Effects of ibogaine on acute signs of morphine withdrawal in rats: independence from tremor by Glick, S D, Rossman, K, Rao, N C, Maisonneuve, I M, Carlson, J N

    Published in Neuropharmacology (01-05-1992)
    “…Because of the claim that ibogaine suppresses the symptoms of "narcotic withdrawal" in humans, the effect of ibogaine on naltrexone-precipitated withdrawal…”
    Get more information
    Journal Article
  19. 19

    Attenuation of the reinforcing efficacy of morphine by 18-methoxycoronaridine by Maisonneuve, Isabelle M, Glick, Stanley D

    Published in European journal of pharmacology (21-10-1999)
    “…In previous studies, 18-methoxycoronaridine, a novel iboga alkaloid congener, has been reported to decrease the self-administration of morphine, cocaine,…”
    Get full text
    Journal Article
  20. 20

    Ibogaine and the dopaminergic response to nicotine by MAISONNEUVE, I. M, MANN, G. L, DEIBEL, C. R, GLICK, S. D

    Published in Psychopharmacologia (01-02-1997)
    “…There is increasing evidence that the rewarding effect of nicotine is mediated by the mesolimbic dopamine system. The first objective of this study was to…”
    Get full text
    Journal Article